Tekturna Approval History
FDA Approved: Yes (First approved March 5, 2007)
Brand name: Tekturna
Generic name: aliskiren
Dosage form: Tablets and Oral Pellets
Previous Name: Rasilez
Treatment for: High Blood Pressure
Tekturna (aliskiren) is a direct renin inhibitor indicated as a once-daily oral therapy for the treatment of high blood pressure.
Development History and FDA Approval Process for Tekturna
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.